Related Experiment Video
Updated: Dec 23, 2025

14:14
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
16.2K
Circulating Tumor Cells: Applications for Early Breast Cancer
Tamara Martos1, David Casadevall1,2, Joan Albanell3,4,5,6
1Servei d'Oncologia Mèdica, Hospital del Mar, Barcelona, Spain.
Advances in Experimental Medicine and Biology
|April 19, 2020
Summary
Identifying high-risk breast cancer patients is crucial. Circulating tumor cells (CTCs) show prognostic value, but further research is needed to integrate CTC detection into early breast cancer (eBC) clinical practice.
Area of Science:
- Oncology
- Molecular Biology
Background:
- Breast cancer is a leading malignancy in women, often diagnosed early with curative intent.
- Relapse occurs in some patients, highlighting the need for better risk stratification.
- Circulating tumor cells (CTCs) show prognostic value in early breast cancer (eBC).
Purpose of the Study:
- To discuss the role of CTCs in identifying high-risk patients for early breast cancer (eBC).
- To explore the potential of CTCs in monitoring tumor dynamics and therapy response.
- To address limitations in current CTC detection methods and suggest future research directions.
Main Methods:
- Review of existing literature on CTCs in early breast cancer (eBC).
- Discussion of current CTC detection methods focusing on epithelial surface markers.
- Exploration of emerging technologies for comprehensive CTC assessment.
Main Results:
- Definitive evidence supports the prognostic role of CTCs in eBC.
- Clinical utility of CTCs in daily practice is currently limited.
- Current methods may not capture tumor heterogeneity or the tumor-immune interplay.
Conclusions:
- Advanced CTC detection methods are needed to overcome current limitations and capture tumor landscape heterogeneity.
- CTCs hold promise for personalizing early breast cancer (eBC) management.
- Liquid biopsy combinations may offer novel insights into tumor biology and patient care.

